Clincosm LogoSign in Get a demo

kidney cancer

Showing 76 - 100 of 405
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Cancer, Thyroid Cancer, Lung Cancer Trial in United States

Recruiting
  • Pancreatic Cancer
  • +49 more
    • Colorado Springs, Colorado
    • +80 more
    Feb 22, 2022

    Advanced Kidney Cancer, Kidney Cancer, Clear Cell Renal Cell Carcinoma Trial in United States (Guadecitabine, Durvalumab)

    Active, not recruiting
    • Advanced Kidney Cancer
    • +2 more
    • Chicago, Illinois
    • +4 more
    Feb 16, 2022

    Clear Cell Renal Cell Carcinoma, Kidney Cancer, Advanced Renal Cell Carcinoma Trial in United States

    Recruiting
    • Clear Cell Renal Cell Carcinoma
    • +2 more
    • Basking Ridge, New Jersey
    • +6 more
    Feb 16, 2022

    Clear-cell Renal Cell Carcinoma, RCC, Kidney Cancer Trial in Birmingham (Avelumab, Sunitinib)

    Withdrawn
    • Clear-cell Renal Cell Carcinoma
    • +3 more
    • Birmingham, Alabama
      University of Alabama Hematology Oncology Clinic at Medical West
    Feb 14, 2022

    Ex VIvo DEtermiNed Cancer Therapy

    Recruiting
    • Bladder Cancer
    • +5 more
    • Functional drug screen
    • Sheffield, South Yorkshire, United Kingdom
      Sheffield Teaching Hospitals NHS Foundation Trust
    Jan 31, 2022

    Kidney Cancer, Head Neck Cancer, Breast Cancer Trial in New York (177Lu-J591)

    Completed
    • Kidney Cancer
    • +8 more
    • New York, New York
      Weill Cornell Medical College
    Feb 1, 2022

    Kidney Cancer, Prostate Cancer Trial in Columbia (Lidocaine Hydrochloride 0.8% in Dextrose 5% Solution, 0.9% Sodium Chloride

    Recruiting
    • Kidney Cancer
    • Prostate Cancer
    • Lidocaine Hydrochloride 0.8% in Dextrose 5% Solution
    • 0.9% Sodium Chloride Injection
    • Columbia, Missouri
      University Hospital
    Jan 21, 2022

    Small Renal Tumors and Primary and Secondary Liver Neoplasms

    Recruiting
    • Liver Cancer
    • +3 more
    • Microwave ablation (MWA)
    • Milano, Italy
      IRCCS Ospedale San Raffaele
    Jan 18, 2022

    Kidney Cancer Trial in United States (Gemcitabine, Sunitinib)

    Completed
    Has Results
    • Kidney Cancer
    • Birmingham, Alabama
    • +98 more
    Dec 29, 2021

    LEARN: Learning Environment for Artificial Intelligence in

    Not yet recruiting
    • Arrhythmias, Cardiac
    • +8 more
      • Saint Leonards, New South Wales, Australia
      • +3 more
      Jan 6, 2022

      Long Non-coding MFI2-AS1 RNA in Localized Clear Cell Kidney

      Recruiting
      • Kidney Cancer
      • Surgical intervention
      • Strasbourg, France
        Les Hôpitaux Universitaires de Strasbourg
      Dec 13, 2021

      Kidney Cancer Trial run by the NCI (INC280)

      Completed
      • Kidney Cancer
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Dec 18, 2021

      To EstablishReproducible Organoid Culture Model With Human

      Completed
      • Kidney Cancer
      • Organoid culture
      • Shatin, Hong Kong
        Prince of Wales Hospital
      Dec 14, 2021

      Cancer, Cancer Metastatic, Tumors Trial in Los Angeles (Elly Mobile Phone Application)

      Recruiting
      • Cancer
      • +22 more
      • Elly Mobile Phone Application
      • Los Angeles, California
        Cedars Sinai Medical Center
      Dec 7, 2021

      Metastatic Renal Cell Carcinoma, Kidney Cancer, Kidney Tumor Trial in Herlev (Electronic patient-reported outcomes regarding

      Not yet recruiting
      • Metastatic Renal Cell Carcinoma
      • +5 more
      • Electronic patient-reported outcomes regarding symptoms and health-related quality of life
      • Herlev, Denmark
        Department of Oncology, Herlev and Gentofte Hospital
      Nov 15, 2021

      Urothelial Carcinoma, Kidney Cancer, Ureter Cancer Trial in Toronto (drug, other, dietary supplement)

      Completed
      • Urothelial Carcinoma
      • +3 more
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      Nov 22, 2021

      Kidney Cancer Trial (Innersight3D)

      Not yet recruiting
      • Kidney Cancer
      • Innersight3D
      • (no location specified)
      Oct 26, 2021

      Cellular Immunity and Renal Cell Cancer

      Completed
      • NK Cell Mediated Immunity
      • +2 more
        • Rijeka, Croatia
          Clinical Hospital Center Rijeka
        Sep 19, 2021

        Kidney Cancer Trial in Houston (Pazopanib, Temsirolimus, Quality of Life Assessment)

        Completed
        Has Results
        • Kidney Cancer
        • Houston, Texas
          University of Texas MD Anderson Cancer Center
        Aug 24, 2021

        Renal Cell Carcinoma; Predicting Biomarkers for Renal Cell

        Recruiting
        • Kidney Cancer
          • Roskilde, Denmark
            Zealand University Hospital
          Sep 16, 2021

          Kidney Cancer Trial in Roskilde

          Recruiting
          • Kidney Cancer
            • Roskilde, Denmark
              Zealand University Hospital
            Sep 16, 2021

            Kidney Cancer, Leukemia, Lymphoma Trial in United States (glutamic acid, )

            Completed
            Has Results
            • Kidney Cancer
            • +5 more
            • glutamic acid
            • placebo
            • Fort Myers, Florida
            • +5 more
            Jul 22, 2021

            Select Advanced Malignancies, Kidney Cancer, Clear Cell Renal Cell Carcinoma Trial in Worldwide (MEDI0680, Durvalumab,

            Completed
            Has Results
            • Select Advanced Malignancies
            • +2 more
            • MEDI0680
            • +2 more
            • Los Angeles, California
            • +26 more
            May 6, 2021

            Kidney Cancer Trial in Boston, Houston, Salt Lake City (Everolimus, Sunitinib)

            Terminated
            Has Results
            • Kidney Cancer
            • Boston, Massachusetts
            • +3 more
            Apr 26, 2021

            Kidney Cancer Trial in New Brunswick (therapeutic allogeneic lymphocytes, sunitinib malate)

            Terminated
            Has Results
            • Kidney Cancer
            • therapeutic allogeneic lymphocytes
            • sunitinib malate
            • New Brunswick, New Jersey
              Rutgers Cancer Institute of New Jersey
            Apr 23, 2021